polaris retatrutide Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset What Is Retatrutide? Triple Agonist

Changes in poop color arent among the most common side effects of GLP-1 medications, but St

While the findings dont establish a clear causal link between GLP-1 drugs and eye disease, experts say theres still reason for caution

2.3 Yurpeak: Ciplas Tirzepatide Franchise In December 2025, Cipla announced the launch of Yurpeak, a once-weekly tirzepatide injection for obesity and type 2 diabetes, under a partnership where: Lilly manufactures and supplies tirzepatide (same price as Mounjaro)

Kahle, M.S

What emerged is a more nuanced picture: what we call type 2 diabetes may actually represent five distinct subtypes, each with different underlying drivers